Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Supplement—May 2025
SUPPLEMENT ISSUE
Supplement
16S Ribosomal RNA Gene PCR and Sequencing for Pediatric Infection Diagnosis, United States, 2020–2023
Table 1
Patient characteristics from study of 16S ribosomal RNA gene PCR and sequencing for pediatric infection diagnosis, Mayo Clinic, Rochester, Minnesota, USA, 2020–2023*
Patient characteristics | Value, n = 124 patients |
---|---|
Median age, y (IQR) |
9.6 (2.2–15.0) |
Sex | |
F | 58 (47) |
M |
66 (53) |
Immunocompromised host† |
24 (20) |
Intensive care unit admission |
46 (37) |
Suspected clinical syndrome | |
Meningoencephalitis | 38 (31) |
Musculoskeletal infection: septic arthritis, osteomyelitis | 33 (27) |
Pleural effusion | 10 (8) |
Surgical wound infection, including hardware infection | 10 (8) |
Lymphadenopathy | 5 (4) |
Bone mass | 4 (3) |
Intracranial abscess/fluid collection | 2 (2) |
Pericardial effusion | 4 (3) |
Pulmonary nodules | 4 (3) |
Traumatic wound infection | 4 (3) |
Intraabdominal abscess/fluid collection | 4 (3) |
Endocarditis | 2 (2) |
Splenic mass | 1 (1) |
Infected pseudoaneurysms | 1 (1) |
Mediastinitis | 1 (1) |
Retinal detachment | 1 (1) |
Suggested by pediatric infectious diseases team | 56 (45) |
*Values are no. (%) patients except as indicated. IQR, interquartile range. †Immunocompromised hosts include those with history of solid organ transplant, history of hematopoietic stem cell transplant, active chemotherapy, or receiving an immunosuppressive agent.
Page created: April 11, 2025
Page updated: May 08, 2025
Page reviewed: May 08, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.